↓ Skip to main content

A novel mutation in CELSR1 is associated with hereditary lymphedema

Overview of attention for article published in Vascular Cell, February 2016
Altmetric Badge

Citations

dimensions_citation
42 Dimensions

Readers on

mendeley
39 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A novel mutation in CELSR1 is associated with hereditary lymphedema
Published in
Vascular Cell, February 2016
DOI 10.1186/s13221-016-0035-5
Pubmed ID
Authors

M. L. Gonzalez-Garay, M. B. Aldrich, J. C. Rasmussen, R. Guilliod, P. E. Lapinski, P. D. King, E. M. Sevick-Muraca

Abstract

Biological evidence reported in the literature supports the role of CELSR1 as being essential for valvular function in murine lymphatics. Yet thus far, there have been no variants in CELSR1 associated with lymphatic dysfunction in humans. In this report, a rare early inactivating mutation in CELSR1 is found to be causal for non-syndromic, lower extremity lymphedema in a family across three generations. Near-infrared fluorescence lymphatic imaging shows that instead of being propelled within the lumen of well-defined lymphatic vessels, lymph moved in regions of both legs in an unusual fashion and within sheet-like structures. CELSRI may be responsible for primary, non-syndromic lymphedema in humans.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 39 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 39 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 14 36%
Researcher 4 10%
Student > Doctoral Student 2 5%
Student > Bachelor 2 5%
Student > Master 2 5%
Other 5 13%
Unknown 10 26%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 9 23%
Medicine and Dentistry 5 13%
Agricultural and Biological Sciences 3 8%
Engineering 3 8%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Other 4 10%
Unknown 14 36%